Betta Pharmaceuticals Co., Ltd.

This study is testing a two-step treatment for advanced non-small cell lung cancer in patients whose previous targeted therapy has stopped working. First, patients receive a short course of chemotherapy, then switch to a different targeted drug called befotertinib. The goal is to…

This study is testing a new combination of two drugs, MCLA-129 and ensartinib, for people with advanced solid tumors that have a specific genetic feature called MET. The first part of the study aims to find a safe and effective dose. The second part will see how well the combinat…

This study is testing a new drug called MCLA-129 in people with advanced cancers, including lung, head and neck, and colorectal cancer, that have progressed after standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. The drug is design…